Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30

$0.98−0.01 (-1.00%)

Close on Nov 13, 2026Market cap $18.88MP/E –Yield –

Cocrystal Pharma gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2011 it was 21.1%.

Period	Period end	Value	Change (pts)
FY2011	Dec 31, 2011	21.1%	–

See a number that looks wrong?